Nearly 5% of patients with cancer die within 1 month of undergoing surgery
the ONA take:
According to new findings presented at the American Society of Clinical Oncology's (ASCO's) 2014 Quality Care Symposium in Boston, Massachusetts, researchers have found that of the more than 1.1 million patients with cancer who underwent surgery, nearly 5% died within 1 month of their surgery.
For the study, the researchers identified more than 1.1 million patients diagnosed with cancer between 2004 and 2001. Of those, 53,498 patients died within the month after undergoing the operation.
In addition, researchers found that married patients had a 20% lower risk of dying within 1 month after surgery compared to unmarried patients. Insured patients had a 12% lower risk of dying within 1 month after surgery compared with uninsured patients, and wealthier patients had a 5% lower risk.
Also, more educated patients had a 2% lower risk of dying compared with less educated patients. In contrast, minority patients had a 13% higher risk of dying within 1 month after surgery, men had an 11% higher risk, and older patients had a 2% higher risk. Patients with advanced cancer had an 89% greater risk of dying within 1 month after surgery. The findings suggest that disparities affect adversely affect surgical outcomes.
Of more than 1.1 million patientswho underwent surgery, nearly 5% died within 1 month.
In a study of more than 1.1 million cancer patients who had surgery, Harvard researchers found that almost 5 percent died within one month of their operation. These findings are scheduled to be presented at the American Society of Clinical Oncology's 2014 Quality Care Symposium, held from Oct. 17 to 18 in Boston. The researchers found that, of the 1.1 million patients diagnosed from 2004 to 2011, 53,498 died within the month after surgery.
Specifically, married patients had a 20 percent lower risk of dying within the month after surgery; insured patients had a 12 percent lower risk; wealthier patients had a 5 percent lower risk; and more-educated patients had a 2 percent lower risk. Conversely, minority patients had a 13 percent higher risk of dying; men had an 11 percent greater risk; older patients had a 2 percent greater risk; and patients with advanced cancer had an 89 percent higher risk.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|